title: Atrial fibrillation and stroke prevention in aging patients: what's good can be even better.
authors.affiliation: From the Division of Cardiology, University of Massachusetts Medical School, Worcester, MA (J.E.F.); and the Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN (B.J.G.). jane.freedman@umassmed.edu.
authors.forename: Jane E
authors.initials: JE
authors.lastname: Freedman
authors.affiliation: From the Division of Cardiology, University of Massachusetts Medical School, Worcester, MA (J.E.F.); and the Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN (B.J.G.).
authors.forename: Bernard J
authors.initials: BJ
authors.lastname: Gersh
mesh_terms: D001281:Atrial Fibrillation / Q000188:drug therapy*; D004617:Embolism / Q000517:prevention & control*; D065427:Factor Xa Inhibitors; D005260:Female; D006801:Humans; D008297:Male; D009025:Morpholines / Q000008:administration & dosage*; D000069552:Rivaroxaban; D020521:Stroke / Q000517:prevention & control*; D013876:Thiophenes / Q000008:administration & dosage*; D014812:Vitamin K / Q000037:antagonists & inhibitors*; D014859:Warfarin / Q000008:administration & dosage*
chemical_list: D065427:Factor Xa Inhibitors; D009025:Morpholines; D013876:Thiophenes; D014812:Vitamin K; D014859:Warfarin; D000069552:Rivaroxaban
keywords: Editorials; aging; anticoagulant; arrhythmia; stroke